Indian Pharmacopoeia Commission (IPC) Organizes National Conference on Quality and Safety of Biosimilars: Strengthening India’s Biopharma SHAKTI Vision

The Indian Pharmacopoeia Commission (IPC) organized a two-day national conference in Bengaluru on the quality and safety of biosimilars to align with the Biopharma SHAKTI Vision. The event focused on addressing regulatory, scientific, and safety challenges in biopharmaceuticals and launched the Indian Pharmacopoeia Reference Substance (IPRS) for Enoxaparin Sodium for bioassays. This reference material is intended to support accurate biological activity assessment and strengthen indigenous pharmaceutical quality infrastructure in line with Atmanirbhar Bharat and Viksit Bharat goals.